GlassScriptPhysician profile
Leah Bowler
NPI 1265017487
$779.53
in general payments reported to CMS, 2019-2025
15 companies · $353 in 2025
The $353 reported for 2025 was more than what 78% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.61 · 2022: $62.77 · 2023: $212 · 2024: $137 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.15 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $342.16 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $77.28 | 2022-2024 | Slynd |
| Abbvie INC. | $68.28 | 2023 | |
| Sumitomo Pharma America, INC. | $44.07 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $38.06 | 2022-2025 | |
| Sage Therapeutics, LLC | $36.71 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $34.39 | 2021-2025 | Aptima |
| Millicent US INC | $22.98 | 2025 | Femlyv |
| Baxter Healthcare | $22.23 | 2023 | Tisseel |
| Urovant Sciences INC | $17.52 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.27 | 2025 | Qelbree |
| Glaxosmithkline, LLC. | $16.98 | 2023 | Boostrix, Shingrix |
| Avion Pharmaceuticals | $15.76 | 2022 | |
| Acella Pharmaceuticals, LLC | $14.34 | 2023 | NP Thyroid 60 |
| Organon LLC | $11.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Bowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.